Price
Target price
€0.28
€0.28
-2.360%
-0.007
-2.360%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Tempramed Technologies Ltd.
sharewise wants to provide you with the best news and tools for Tempramed Technologies Ltd., so we directly link to the best financial data sources.
Financials
News
TempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering Over 1 million Lives
Acceptance of TempraMed’s products by Meuhedet Health Services strengthens TempraMed's B2B institutional commercialization strategy as the Company advances reimbursement initiatives and
TempraMed Signs LOI for Exclusive Distribution in Kuwait, Expanding Presence in High-Growth Gulf Region Healthcare Market
Highlights
- TempraMed signs non-binding LOI for exclusive distribution in Kuwait with Elegir Trading
- Kuwait represents a high-value market with significant demand for
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
Toronto, ON – June 30, 2026 – TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY)
TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart Product
Another major milestone in its continuous global IP strategy, advancing protection of VIVI Cap Smart across international markets
Highlights
- Granted Patent covers the design